Characteristics of drop outs in a longitudinal study on individuals at risk for a neurodegenerative disorder
Objective: To evaluate potential differences in cognitive, motor and demographic factors between individuals who are lost to follow-up in the longitudinal Tuebinger evaluation of Risk…Fall prediction in Parkinson’s disease based on motor dual-tasking: Evidence from the prospective MODEP study
Objective: To evaluate the predictive value of dual-task performance for future falls in patients with Parkinson's disease (PD). Background: Falls entail very severe health-related consequences…Cognition and amyloid biomarker status in non-demented patients with Parkinson’s disease patients (PD) with or without subjective cognitive decline (SCD)
Objective: To compare the cognitive and Amyloid-beta 1-42 profile of non-demented Parkinson's disease patients (PD) reporting subjective cognitive decline (SCD) with or without concerns regarding…Impulsive action tendencies in GPi DBS Parkinson’s patients
Objective: To test the effects of GPi DBS on susceptibility to impulsive action errors and the proficiency of reactive inhibitory control to counteract interference from…The effect of statin use on cognition in Parkinson’s disease
Objective: To evaluate the effect of statin (HMG CoA reductase inhibitor) use on 1) baseline cognition; 2) rate of cognitive decline; and 3) conversion from…Baseline physical activity may influence exercise-induced changes in cognitive function in Parkinson’s disease
Objective: To determine how physical activity (PA) levels influence disease severity and cognitive function changes as a result of exercise in Parkinson's disease (PD). Background:…Self-reported cognitive complaints and neuropsychological performance in idiopathic REM sleep behavior disorder
Objective: The aim of this study was to investigate self-reported cognitive complaints in idiopathic REM sleep behavior disorder (iRBD) in link with the presence of…Effect of rivastigmine in Parkinson’s disease dementia – A logitudinal observational study
Objective: Outcome of Rivastigmine treatment in Parkinson's disease Dementia (PDD). Effect of treatment on cognition and Neuropsychiatric symptoms. To compare clinical global impression of Clinicians…Impairment of decision-making processes in patients with Parkinson’s disease during a strategic game
Objective: To characterize differences in choice patterns, and differentiate the effects of dopaminergic (DA) treatment on motor and cognitive function, during dynamic decision-making in Parkinson's…Apolipoprotein E genotypes in Brazilian patients with Parkinson’s disease and their correlation with cognitive performance assessed by MoCA
Objective: Analysing the relationship between the polymorphisms of ApoE gene and cognitive performance of patients with Parkinson's disease. Background: Cognitive impairment is a common clinical…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.